PURPOSE This study was designed to evaluate the impact of electronic medical record (EMR) implementation on quality of diabetes care.
INTRODUCTION
Q uality of outpatient diabetes care lags behind evidence-based care recommendations, 1, 2 and various strategies have been suggested to improve care. [3] [4] [5] [6] [7] Electronic medical records (EMRs) have been proposed as an effective information management tool with the potential to improve diabetes care, [8] [9] [10] and an Institute of Medicine report has identifi ed key features of EMRs that may lead to better care. 10 Currently available outpatient EMRs can identify patients with diabetes, assess whether the patient is due for recommended tests or screening procedures, and determine which patients have not achieved evidence-based clinical goals for glycemic, lipid, or blood pressure control. This information is typically presented to the clinician as reminders (patient due for a glycated hemoglobin [HbA 1c ] test) or prompts (patient's HbA 1c level is above recommended level) delivered electronically at the point of care. Current diabetes care is characterized by high rates of clinical inertia, defi ned as failure to intensify treatment in patients who have not achieved evidence-based clinical goals. 11, 12 Rates of clinical inertia at diabetes visits exceed 50%, and EMR technology seems well-suited to reducing this problem, thus improving care.
Currently only about 20% of primary care physicians report use of EMRs. Because of the well-established administrative and fi nancial management advantages of EMRs and the pressure from payers, purchasers, and regulators of health care to use EMRs, investments in such technology are rapidly increasing. This rapid growth in EMR use is driven in part by a widespread belief that EMR use will improve clinical care.
Many uncontrolled studies have reported improvements in diabetes care temporally linked to EMR use. Because there is evidence of a widespread improvement trend in diabetes care in recent years, [13] [14] [15] [16] uncontrolled studies may overestimate the benefi ts of EMRs . 17 In controlled studies, current EMR systems have had limited positive impact on outpatient diabetes care. [18] [19] [20] No study yet has found that EMR use has a signifi cantly positive impact on glycemic control, although improvements in some diabetes processes of care have been documented. This study differs from previous reports by focusing on community primary care practices and evaluating the impact of a commercially available EMR used to provide all offi ce care, not only diabetes care.
METHODS
This study was designed to assess whether implementation of an EMR in a primary care clinic signifi cantly improves process of care (appropriate frequency of testing for HbA 1c and low-density lipoprotein [LDL]) or intermediate outcomes of care (change in HbA 1c and LDL levels) for adults with diabetes mellitus.
Study Setting
The study was conducted at HealthPartners Medical Group (HPMG), a multispecialty medical group in Minnesota that provided care to 175,000 adults in 18 clinics in 1996. The study was designed to take advantage of EMR implementation in 1 clinic of a multiclinic medical group by comparing results with those achieved in a clinic that was not using the EMR. On May 7, 1997, an EMR developed by Epic Systems was introduced at the intervention clinic, with extensive formal and ongoing one-on-one support provided to physicians. This EMR system included visit notes typed by physicians, automated ordering of pharmaceuticals, current displays of all laboratory and test results on request, a problem list, and other features. Physicians typically consulted the EMR on a computer monitor while in the examination room with each patient. All clinical data were loaded from several previous years, and after EMR implementation, paper charts were no longer available at the time of patient visits. An EMR enhancement in March 1998 included prompts to physicians if a patient with diabetes had no HbA 1c test within 6 months or no urine microalbuminuria test within 1 year. In mid-1999, further enhancements included prompts to physicians when diabetic patients had blood pressures of ≥130/85 mm Hg, LDL levels of ≥130 mg/dL, HbA 1c levels ≥8%, or no aspirin use if aged 40 years or older. The prompts and reminders were visible on the screen, but a response to them was not obligatory. At no time during this study was the EMR widely used to provide information or printouts directly to patients.
The EMR clinic was relatively small, with a stable staff of 4 to 5 physicians, and was a system leader in quality of care. The comparison clinic was selected because it was similar to the EMR clinic in size, physician stability, and suburban location, and the diabetic patients had similar baseline HbA 1c test values. No residency training was done at either study clinic.
The EMR evaluated in this report was developed by Epic Systems (Madison, Wis) and updated regularly as new systems and technology were developed. Support was provided through Information Services at HealthPartners, with expert consultation from Epic as needed. The cost of the EMR at this clinic is not available for public disclosure, but more resources were invested in EMR implementation and maintenance than were invested for other care improvement interventions at the comparison clinic or at other clinics in the medical group during the study period. The EMR clinic participated in other diabetes-related care improvement activities within the medical group during the study period, as previously described. 13 All clinics in the medical group had access to physician-specifi c diabetes registries that were distributed quarterly in printed form, in-clinic diabetes teaching nurses for patient education, and a common diabetes clinical guideline developed regionally by the Institute for Clinical Systems Improvement (http://www.icsi.org).
The EMR used a Windows interface and a Virtual Basic (Microsoft Corp, Redmond, Wash) operating system linked to laboratory test results and pharmacy databases. Each examination room had a computer screen and keyboard, and physicians typically constructed offi ce notes and orders while in the examination room with the patient. Although we did not formally evaluate acceptability of the EMR to physicians or patients in this study, it is widely believed at the EMR clinic and within HPMG that both physicians and patients are quite satisfi ed with the system.
Study Patients
To evaluate the impact of the EMR on process and intermediate outcomes of diabetes care, we focused on all adults with an established diagnosis of diabetes at study baseline in both study clinics. Those older than 18 years were classifi ed as having diabetes mellitus if in calendar year 1994 they had either (1) 1 or more inpatient or 2 or more outpatient ICD-9 codes for diabetes (ICD-9 codes 250.xx), or (2) a fi lled prescription for a diabetes-specifi c drug (insulins, sulfonylureas, metformin, thiazolidinediones, alpha-glucosidase inhibitors, meglitinides). This EMRS AND DIABETES CARE diabetes identifi cation method was previously evaluated with estimated sensitivity of 0.91, specifi city of 0.99, and positive predictive value of 0.94. 21 The clinic that each diabetes patient attended was identifi ed in 1996, 1998, and 2000 based on number of visits and administrative data. Patients were included in the analysis only if they attended their original study clinic in all 3 of the study years and were still alive and enrolled in HPMG on December 31, 2000. We have previously shown that disenrollment rates for diabetes patients averaged 3.9% a year from 1993 to 1996, and that the HbA 1c level was not a signifi cant predictor of either death or disenrollment in adults with diabetes. 22 There were 122 study patients who met these inclusion criteria and whose diabetes care data are analyzed in this report; of these patients, 57 received care at the EMR clinic and 65 received care at the comparison clinic. 23 with a coeffi cient of variation of 0.58% at an HbA 1c value of 8.8% and a normal range of 4.5% to 6.1%. In October 1998 a minor modifi cation of the assay method was made, which did not change median HbA 1c values, but which led to statistically signifi cant lower values for HbA 1c concentrations of more than 10%. This change in assay applied equally to both clinics in the study in both timing and degree.
Dependent Variables
LDL cholesterol (LDL) was calculated from measures of total cholesterol, high-density lipoprotein cholesterol, and fasting (12 hours or more) triglycerides using a standard equation. 24 All lipid assays were done in the same accredited clinical chemistry laboratory using standard assay techniques that did not change during the study period.
All test results from both clinics were entered directly into an electronic database at the central laboratory. In the EMR clinic, results were then downloaded into Epic. When collecting data for analysis, we drew all data from the electronic database at the central laboratory, assuring equivalent and complete capture of relevant laboratory test data for the EMR and comparison clinics. Neither clinic used desktop analyzers for any tests during the study period.
Independent Variables
There were 2 independent variables of interest. The fi rst was an indicator of EMR use. The second was an indicator of the year (1996, 1998, or 2000) in which the outcome measures were taken. The interaction between these 2 independent variables constituted the effect of most interest for the study. 26 and Rush et al. 27 The modifi cations of Rush et al included (1) assigning points only when a diagnostic code appears 2 or more times during a 12-month period, and (2) excluding all points related to diabetes, because every patient in the analysis was identifi ed as having diabetes as a condition of being in the study. This modifi ed Charlson score has been validated and found to predict both mortality and costs of care. 27 Because of the nonnormal distribution of the Charlson score, patients were grouped and analyzed according to whether their Charlson score was less than 2, 2, or more than 2.
Plan of Analysis
The analysis was designed to test 3 hypotheses: (1) EMR use predicts the number of HbA 1c and LDL tests performed, (2) EMR use predicts the proportion of patients with recommended number of HbA 1c and LDL tests in a given year, 28, 29 and (3) EMR use predicts change in values of HbA 1c and LDL tests with time.
Generalized linear modeling techniques (SAS version 8.2, SAS Institute, Cary, NC) were used to predict whether dependent variables changed with time in the EMR and comparison settings. Normally distrib-uted continuous outcome variables (test values) were predicted using PROC MIXED, specifying a normal distribution and identity link function. PROC GEN-MOD was used for binary outcomes (testing thresholds) specifying a logit link function and a binomial distribution. Number of tests was predicted using both the normal distribution with an identity link function and the Poisson distribution with a log link function in PROC GENMOD with identical results. In all models, the unit of analysis was the patient, and the covariance structure among the repeated measures was unspecifi ed. We evaluated relevant interaction terms and included those that were signifi cant.
Human Subjects Protection
The study was reviewed in advance, approved, and monitored by the HealthPartners Institutional Review Board. Table 1 shows that study patients at the 2 clinics had similar age, sex, and Charlson score distributions. Table 2 shows that the number of HbA 1c tests performed per patient per year in the EMR clinic increased signifi cantly relative to the number of HbA 1c tests at the comparison clinic both 2 years (P <.04) and 4 years (P <.001) after the EMR was introduced. There were no signifi cant effects of any other covariates on HbA 1c test rates. The number of LDL tests performed per patient per year signifi cantly increased from 1996 to 2000 in both clinics (P <.001), with no signifi cant difference in the rate of increase between the EMR and comparison clinics. There were no signifi cant effects of any other covariates on LDL test rates.
RESULTS
Next, we tested whether the proportion of patients receiving the recommended number of HbA 1c tests increased with time in the EMR clinic relative to the comparison clinic. The increase in predicted testing rates in the EMR clinic in 1998 was only marginally larger than the increase in the comparison clinic, from 55.4% in 1996 to 63.1% in 1998, P = .09 (Table 3) . Through 2000, however, the predicted test rates increased further in the EMR clinic but not in the comparison clinic, P = .02. There were no signifi cant effects involving any of the covariates.
An analogous model predicted LDL tests and showed a different pattern of results. The predicted proportion of patients meeting the LDL testing standard at both clinics had increased by year 2000 (P <.001); however, there were no signifi cant differences in LDL test rate between clinics either 2 years (P = .12) or 4 years (P = .12) after EMR implementation.
A third model tested whether the proportion of patients who met both the HbA 1c and LDL testing thresholds increased with time and by EMR clinic. The predicted proportion of patients meeting both the HbA 1c and LDL thresholds increased signifi cantly from 1996 to 1998 (P <.05), and showed an even greater increase from 1996 to 2000 (P <.01). The increase between 1996 and 1998 was similar in the EMR and comparison clinics (P = .27), but the increase between 1996 and 2000 was larger in the EMR than in the comparison clinic (P = .03). Table 4 and Figure 1 show that patients in the EMR and comparison clinics had similar HbA 1c values in 1996. These values were stable from 1996 to 1998 but improved signifi cantly by year 2000 (P < .05). Patients at the EMR clinic, however, did not have more improvement in HbA 1c values than their non-EMR counterparts either 2 years (P = .10) or 4 years (P = .27) after EMR implementation. The only signifi cant effect involving covariates showed that older patients had lower HbA 1c values (P <.0002).
Although we had planned to also analyze the relationship of EMR status on change in LDL levels with time, there were too few patients with LDL measurements during the 3 periods to provide stable statistical estimates. The results of these analyses are therefore not shown. There was no evidence, however, that EMR use led to lower LDL levels.
DISCUSSION
In this study EMR use was associated with improved process of care for adults with diabetes. Patients who attended the EMR clinic had more HbA 1c tests than patients in the comparison clinic, and more patients in the EMR clinic met recommended thresholds for HbA 1c and LDL test frequency than did patients in the comparison clinic. There was no evidence, however, that this change in process of care led to better glycemic control in the EMR clinic patients during the 4-year follow-up period.
Implications of Findings for EMR Design
The data suggest that despite the substantial cost and increasing technical sophistication of EMRs, EMR use failed to achieve desirable levels of clinical improvement. Although it is commendable to perform regular HbA 1c testing, it is the HbA 1c level, not the number of HbA 1c tests done, that predicts future risk of complications and increased health care costs. [30] [31] [32] Moreover, recommendations for HbA 1c test frequency are not based on clinical trial data, but on expert opinion, whereas the HbA 1c level has been shown in clinical trials to be a strong predictor of outcomes and a moderate predictor of costs. The tenuous link between process and outcome of diabetes care is well described in the literature; frequency of tests and procedures is not strongly linked to HbA 1c levels or clinical events. 33, 34 HbA 1c levels at both study clinics had been improving steadily for 4 years before implementation of the EMR. After EMR implementation, HbA 1c levels in the EMR clinic worsened for a period of about 2 years. This fi nding suggests an urgent need to develop more effective and less disruptive methods of introducing EMRs into clinics. Figure 1 shows that the slope of improvement for HbA 1c levels in the EMR clinic was similar that for the non-EMR clinic after the EMR implementation period. This observation underscores that there are many ways to improve HbA 1c levels in the absence of EMRs-in fact, most recent reports of successful improvement in HbA 1c levels in the published literature were accomplished without the aid of EMRs. [13] [14] [15] [16] That the EMR clinic did not outperform the non-EMR clinic indicates the need to further enhance the capabilities of EMRs. Based on our work and that of others, there are 2 particular domains of care where EMR performance needs major improvement. 35, 36 The fi rst domain is more sophisticated clinical decision support. For example, EMRs can integrate data on patient age, current HbA 1c , levels, renal function, liver function, comorbid conditions, and current medications to recommend specifi c changes in treatment that may be benefi cial. Algorithm-driven decision support is now becoming more widely available in commercial EMRs, but it is utilized only in a minority of practices. 10, 37 The second unrealized frontier is effective use of the EMR as a patient education and patient activation tool. 38, 39 Although computerized information support to patients has shown promise in recent studies, 40 additional strategies, such as patient access to the medical record, prompts and reminders to patients, and generation of customized information and educational materials through EMR databases, should be more completely developed and evaluated.
Limitations of the Study
There are a number of factors that limit the interpretation of the data presented here. First, we tested only 1 EMR version. Future versions of the EMR that include more advanced decision support and patient activation features may lead to greater improvements in care. Second, it is possible that unmeasured factors differentially distributed across groups could have affected our results. Patient demographic differences were small, however, and the analysis controlled for relevant patient characteristics including age, sex, and comorbidity. It is unlikely that results are due to differences in physicians, because similar primary care physicians from the same medical group staffed both clinics, and in other analyses the proportion of variance in diabetes care attributable to physicians has been small. [41] [42] [43] A ceiling effect cannot account for the results, because the mean HbA 1c level in the fi nal year of the study was 7.4%, substantially higher than the recommended goal of HbA 1c level of less than 7%.
It is worth noting that our fi nding of the lack of impact of EMRs on HbA 1c levels is mirrored by other recent reports showing lack of signifi cant impact of EMRs on lipid control, 19 blood pressure control, 44 and treatment of patients with heart disease. 45 Our data suggest the need to incorporate improved clinical decision support and more potent patient activation applications if EMRs are to fulfi ll their promise as an effective tool to improve diabetes care. Medical groups considering EMR systems should carefully evaluate EMR capacity to provide sophisticated clinical decision support, patient education, and activation and to support other functions that have been linked to better chronic disease care, such as diabetes registries, active outreach, and visit planning. In the absence of more advanced EMR capabilities, less expensive and less disruptive care-improvement strategies may improve chronic disease care as effectively as EMRs.
